Autopsy report · NCT00585559
Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm
Cause of deathNo reason given
Life of this trial
- Registered 8 months after it had already started.
- Ran for about 16 years 6 months before it stopped.
- 44 participants enrolled.
- Results were posted on the registry 1 year 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Vanderbilt University Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Aneurysmal Subarachnoid Hemorrhage; Cerebral Vasospasm
- Interventions
- Placebos for acetaminophen and N-acetylcysteine; APAP 1 gm every 6 hours and N-acetylcysteine placebo; NAC IV infusion at 0.5 gm hourly and APAP placebo; APAP 1 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly; APAP 1.5 gm q6 hours, plus NAC IV infusion at 0.5 gm hourly
- Participants
- 44
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.